| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3858636 | The Journal of Urology | 2015 | 8 Pages |
Abstract
Ki-67 was validated as an independent predictor of recurrence-free survival and cancer specific survival in patients treated with extirpative surgery for high grade upper tract urothelial carcinoma in a large, multi-institutional cohort.
Keywords
CISRFSTMACSSRNUNRILNDUTUCLVIKi-67 antigenCancer specific survivalRecurrence-free survivalNet reclassification improvementLymph node dissectionLymphovascular invasionTransitional cellUrinary tractTissue microarraybiological markersRadical nephroureterectomyUpper tract urothelial carcinomaCarcinoma in situCarcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Laura-Maria Krabbe, Aditya Bagrodia, Ahmed Q. Haddad, Payal Kapur, Dina Khalil, Linda S. Hynan, Christopher G. Wood, Jose A. Karam, Alon Z. Weizer, Jay D. Raman, Mesut Remzi, Nathalie Rioux-Leclercq, Andrea Haitel, Marco Roscigno, Christian Bolenz,